Close

Neptune Tech (NEPT) Granted New U.S. Continuation Patet for Alzheimer's Treatment

April 24, 2014 12:12 PM EDT Send to a Friend
Neptune Technologies & Bioressources Inc (Nasdaq: NEPT) announced that the U.S. Patent & Trademark Office (the "USPTO") has granted Neptune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login